Answers are grounded in this paper and cite their sources.
Despite the withdrawal of pentavalent-antimonials in treating Visceral leishmaniasis for more than a decade, recent clinical isolates of Leishmania donovani (LD) exhibit unresponsiveness towards pentavalent-antimony (LD-R). This antimony-unresponsiveness points towards a genetic adaptation that underpins LD-R’s evolutionary persistence and superiority over sensitive counterparts. This study highlights LD’s response to antimony exposure in terms of increased potential of scavenging host-derived iron within its parasitophorous vacuoles (PV). LD-R employs a strategy to both produce and rapidly scavenge host-iron in a ROS-dependant manner, and selectively reshuffle iron exporter, Ferroportin, around its PV. Higher iron utilization leads to subsequent iron-insufficiency, compensated by increased erythrophagocytosis facilitated by the breakdown of SIRPα, orchestrated by a complex interplay of two proteases, Furin and ADAM10. Understanding these mechanisms is crucial for managing LD-R infections and their associated complications, like anemia, and may also provide valuable insights into understanding resistance developed in other pathogens that rely on host iron.
No takes yet. Share an insight, caveat, or question.
Ghosh et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: